In light of the protracted phase 1 clinical trial: is the BOD/management confident in their ability to expedite the anticipated follow-on pivotal trial? What are some of the key trial design features shareholders could expect for a pivotal trial?
In light of the protracted phase 1 clinical trial: is the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $3.221M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.5¢ | $14.24K | 949.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 128940 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 5915049 | 11 |
View Market Depth
| Last trade - 10.01am 14/07/2025 (20 minute delay) ? |
| IBX (ASX) Chart |